PMID- 30145913 OWN - NLM STAT- MEDLINE DCOM- 20190611 LR - 20211204 IS - 1473-0766 (Electronic) IS - 0951-3590 (Linking) VI - 35 IP - 1 DP - 2019 Jan TI - Follicle loss and PTEN/PI3K/mTOR signaling pathway activated in LepR-mutated mice. PG - 44-48 LID - 10.1080/09513590.2018.1490714 [doi] AB - Female mice (Y123F) with substitution mutations introduced through homologous gene targeting, replacing the three tyrosine residues of LepR, Tyr985, Tyr1077, and Tyr1138 with phenylalanine, could induce infertility. This study aimed to describe the reproductive alteration and to explore its mechanism. We compared the reproductive characteristics in the female homozygous (HOM) Y123F mice and wild-type (WT) littermates, analyzing the expression of downstream molecules of LepR, like protein kinase B (Akt)/mammalian target of rapamycin (mTOR), phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and insulin receptor substrate (IRS) in the ovaries. The results showed that 10-week old female Y123F HOM exhibited no reproductive periods, declined anti-mullerian hormone (AMH) levels in the serum and ovaries, reduced primordial follicles, primary follicles, secondary follicles, antral follicles and hardly no corpus lutea (all p < .05). The phosphorylation of downsream Akt, mTOR, S6K1 and eIF4B of LepR were all elevated in the ovaries of the mutated female mice. They also presented a decreased phosphorylation of IRS-1, IRS-2, and PTEN, and a strengthened phosphorylation of FOXO-3A in the ovaries. In conclusions, LepR mutation could result in follicle loss and activation of PTEN/PI3K/Akt/mTOR pathway in adult female mice, independent of insulin signaling pathway. FAU - Xia, Hexia AU - Xia H AD - a Department of Reproductive Endocrinology, Obstetrics and Gynecology Hospital , Fudan University , Shanghai , People's Republic of China. AD - b Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases , Shanghai , People's Republic of China. FAU - Zhang, Ruixiu AU - Zhang R AD - a Department of Reproductive Endocrinology, Obstetrics and Gynecology Hospital , Fudan University , Shanghai , People's Republic of China. AD - b Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases , Shanghai , People's Republic of China. FAU - Guan, Haiyun AU - Guan H AD - a Department of Reproductive Endocrinology, Obstetrics and Gynecology Hospital , Fudan University , Shanghai , People's Republic of China. AD - b Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases , Shanghai , People's Republic of China. FAU - Zhang, Wei AU - Zhang W AD - a Department of Reproductive Endocrinology, Obstetrics and Gynecology Hospital , Fudan University , Shanghai , People's Republic of China. AD - b Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases , Shanghai , People's Republic of China. LA - eng PT - Journal Article DEP - 20180826 PL - England TA - Gynecol Endocrinol JT - Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology JID - 8807913 RN - 0 (Insulin) RN - 0 (Receptors, Leptin) RN - 80497-65-0 (Anti-Mullerian Hormone) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.1.3.67 (PTEN Phosphohydrolase) SB - IM MH - Animals MH - Anti-Mullerian Hormone/metabolism MH - Female MH - Infertility, Female/genetics/*metabolism MH - Insulin/metabolism MH - Mice MH - Oocytes/metabolism MH - Ovarian Follicle/*metabolism MH - PTEN Phosphohydrolase/*metabolism MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Phosphorylation MH - Receptors, Leptin/*genetics/metabolism MH - Signal Transduction/*physiology MH - TOR Serine-Threonine Kinases/*metabolism OTO - NOTNLM OT - AMH OT - Leptin receptor OT - PTEN OT - mTOR OT - primordial follicle EDAT- 2018/08/28 06:00 MHDA- 2019/06/14 06:00 CRDT- 2018/08/28 06:00 PHST- 2018/08/28 06:00 [pubmed] PHST- 2019/06/14 06:00 [medline] PHST- 2018/08/28 06:00 [entrez] AID - 10.1080/09513590.2018.1490714 [doi] PST - ppublish SO - Gynecol Endocrinol. 2019 Jan;35(1):44-48. doi: 10.1080/09513590.2018.1490714. Epub 2018 Aug 26.